Two connected solutions: Medicine Loop asks whether another supply is needed. Medicines Resource Intelligence asks whether a clinically necessary medicine is being delivered through the right resource pathway.
Prevent unnecessary repeat supply before it enters the system.
Uses: prescribing, dispensing, expected consumption, medication changes, reconciliation and stock signals.
Routine stable cases should pass with minimal friction. Stronger checks only appear where timing, stock, medication change or reconciliation signals suggest that another supply decision deserves review.
Optimise the resource pathway for medicines that are genuinely required.
Looks at: route, formulation, preparation, aseptic production, nursing time, chairs, beds, consumables and unused preparations.
Ready-to-administer supply, route optimisation, dose banding, batching, preparation-location redesign and repeated prepared-but-unused doses, all subject to clinical governance.
Repeat prescribing should not restart from zero every month.
Confirm the current authorised medication and relevant recent changes.
Compare the repeat request with supply timing, expected consumption, stock and medication changes.
Resolve dose changes, discontinuations, admissions, discharge changes and duplication before supply.
Supply the clinically required medicine and record quantity and timing.
Capture the strongest available signal of use, remaining stock, return or disposal.
Feed the previous cycle into the next repeat decision instead of starting blind again.
A clinically necessary medicine may still consume avoidable preparation, administration, chair, bed or staffing resource.
Selected repeat-medicine cohorts across participating GP and pharmacy pathways.
Primary proof: Avoided unnecessary items, discrepancies resolved, workload, safety and patient experience.
Selected high-volume or resource-intensive injectable/SACT pathways.
Primary proof: Pharmacy and nursing minutes, aseptic preparations, chair/bed capacity, pathway cost and safety.
Structured capture of selected prepared medicines that are not administered.
Primary proof: Unused-dose rate, discarded value, repeated root causes and post-intervention reduction.
Every benefit should have a Resource Recovery Record: signal, intervention, approval where relevant, observed outcome, benefit type and verification status.
Cash release, cost avoidance and capacity release stay separate. If the intervention costs more professional time than it releases, it has failed economically.
The programme supports better-informed decisions. It does not replace prescribing authority or clinical judgement.